Natalizumab Biosimilar, Endotoxin 0.05 EU/mg
$900.00 – $1,800.00
Natalizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Natalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C055P.05 |
|---|---|
| Product Name | Natalizumab Biosimilar, Endotoxin 0.05 EU/mg |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | ITGA4, CD49D, IA4, integrin subunit alpha 4 |
| Summary | Recombinant Humanized IgG4 Monoclonal Antibody. |
| Isotype | Human IgG4 kappa. |
| Source/Host | The anti-human Integrin α4 monoclonal antibody natalizumab biosimilar was produced in the natalizumab biosimilar CHO stable cell line. |
| Specificity/Sensitivity | The in vivo grade natalizumab biosimilar specifically binds to the human Integrin α4. |
| Form Of Antibody | 0.2 uM filtered solution, pH 6.0, no stabilizers or preservatives. |
| Endotoxin | < 0.05 EU per 1 mg of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The Natalizumab Biosimilar, Endotoxin 0.05 EU/mg is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade Natalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG4 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C055P.05: Natalizumab Biosimilar, Endotoxin 0.05 EU/mg
Recombinant Humanized IgG4 Monoclonal Antibody.
Background
Natalizumab Biosimilar uses the same protein sequences as the therapeutic antibody natalizumab.
Natalizumab is a monoclonal anti-integrin antibody which binds to the alpha 4 subunit of integrins to prevent migration of immune cells, and is used to treat Crohn’s disease or multiple sclerosis.
Humanized IgG4k monoclonal antibody produced in murine myeloma cells. Natalizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to a4-integrin.
Binds to the α4-subunit of α4b 1 and α4b 7 integrins expressed on the surface of all leukocytes except neutrophils, and inhibits the α4-mediated adhesion of leukocytes to their counter-receptor(s).
Syd Labs also provides the following anti-integrin alpha 4 antibody biosimilar proteins:
Volociximab Biosimilar, research grade, anti-human integrin α5β1 monoclonal antibody
Please remember our product information: Natalizumab Biosimilar, Endotoxin 0.05 EU/mg: C055P.05 Syd Labs
Additional information
| Ship from Country | USA |
|---|---|
| Size | 20 mg, 5 mg |
